W. Budts et al., Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxicpulmonary hypertension and pulmonary vascular remodeling in rats, CIRCULATION, 102(23), 2000, pp. 2880-2885
Citations number
45
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Nitric oxide (NO) is a potent vasodilator with an important role
in the regulation of pulmonary vascular tone. The effects of NO synthase (
NOS) gene transfer on pulmonary vascular remodeling associated with hypoxic
pulmonary hypertension are unknown.
Methods and Results-We aerosolized 3X10(9) pfu of an adenoviral vector cont
aining inducible NOS gene (AdNOS2), constitutive NOS3 gene (AdNOS3), or no
transgene (AdRR5) into rat lungs. Exhaled NO levels, monitored with chemilu
minescence, were higher in AdNOS2-infected rats than in AdNOS3- and AdRR5-i
nfected rats (at 3 days, 33+/-6 ppb, n=9, versus 17+/-4, n=9, and 6+/-2 ppb
, n=3, P<0.05 for both). Exposure to FIO2 0.10 for 7 days increased pulmona
ry artery pressure from 19+/-4 mm Hg (baseline) to 27+/-1 and 26+/-2 mm Hg
in AdNOS3- and AdRR5-infected rats, respectively, but only to 21+/-1 mm Hg
in AdNOS2-infected animals (P<0.05). After 7 days of hypoxia, total pulmona
ry resistance in AdRR5- and AdNOS3-infected rats was significantly higher t
han in AdNOS2-infected animals (0.41+/-0.05 and 0.39+/-0.07 versus 0.35+/-0
.03 mmHg . mL(-1) . min(-1), respectively; P<0.05). Right ventricular hyper
trophy was reduced in AdNOS2-infected rats [right ventricular/(left ventric
ular+septal) weight, 0.19+/-0.10 versus 0.28+/-0.10 and 0.32+/-0.10 in AdRR
5- and AdNOS3-infected rats, respectively, P<0.05]. The percentage of muscu
larized precapillary pulmonary resistance vessels was also significantly de
creased (18+/-4% versus 25+/-8% and 30+/-5% in AdRR5- and AdNOS3-infected r
ats, P<0.05).
Conclusions-Aerosol NOS2 gene transfer increases pulmonary NO production an
d significantly reduces hypoxic pulmonary hypertension and pulmonary vascul
ar remodeling. Aerosol NOS2 gene transfer may be a promising strategy to ta
rget pulmonary vascular disorders.